• Tidak ada hasil yang ditemukan

Hubungan Antara Tumor-Infiltrating Lymphocytes (TlLS) dan Grading Histopatologi Pada Triple Negative Breast Cancer (TNBC)

N/A
N/A
Protected

Academic year: 2017

Membagikan "Hubungan Antara Tumor-Infiltrating Lymphocytes (TlLS) dan Grading Histopatologi Pada Triple Negative Breast Cancer (TNBC)"

Copied!
3
0
0

Teks penuh

(1)

29

DAFTAR PUSTAKA

Abraham L.Kierszenbaum, and Laura L. Tres 2012 Immune-Lymphatic System.

Histology and Cell Biology : An Introduction to Pathology. Published by

Elsevier 346-347

American Cancer Society. What is Breast Cancer? Available online at

http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-what-is-breast-cancer (Diakses 28 April 2015)

Ankita Singh Rathore. Et. al Prognostic Impact of CD3 Tumor Infiltrating

Lymphocytes in Triple-negative Breast Cancer. Indian Journal of Clinical

Practice, Vol. 24, No. 4, September 2013

Brouckaert O., Wildiers H., Floris G., Neven P. 2012. Update on triple-negative

breast cancer: prognosis and management strategies. International Journal of Women‟s Health 2012:4 511–520

Carey Anders, MD and Lisa A. Carey, MD 2008.Understanding and Treating

Triple-Negative Breast Cancer.National Institude of Health;22(11):

1233–1243

Carrie L. Griffiths, MA, PharmD1 2012. Triple Negative Breast Cancer: A Brief

Review of its Characteristics and Treatment Options. Journal

ofPharmacy Practice vol. 25 no. 3 319-323

Coleman, M.P. et al 2008, Cancer survival in five continents: a worldwide

population-based study (CONCORD). Lancet Oncol 2008; 9: 730–56

Cornelia Liedtke,.et. al. 2008. Response to Neoadjuvant Therapy and Long-Term

Survival in Patients With Triple-Negative Breast Cancer. Journal

ofClinical Oncology 26:1275-1281

Dan L. Longo, MD, Anthony S. Fauci, MD, Dennis L. Kasper, MD, Stephen L.

Hauser, MD, J. Larry Jameson, MD, PhD and Joseph Loscalzo, MD,

(2)

30

PhD 2012, „Breast Cancer‟ in Harrison’s Principle of Internal Medicine. Published by McGraw Hill Medical 754-763

Dr. Shaheenah Dawood 2010 Triple Negative Breast Cancer.Drugs Published by

Adis, 2247-2258

Emad A Rakha et al 2010. Breast cancer prognostic classification in the molecular

era: the role of histological grade. Breast Cancer Research2010,12:207

Gaol H.L dan Briani F. 2014 „Kanker Payudara‟ in „Kapita Selekta Kedokteran

GLOBOCAN – BREAST CANCER ESTIMATED INCIDENCE, MORTALITY

AND PREVALENCE WORLDWIDE IN 2012. Available online at

http://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp (Diakses 28

April 2015)

Gluz O., Liedtke C., Gottschalk N., PusztaiL., Nitz U., Harbeck N. 2009.

Triple-negative breast cancer - current status and future directions. Annals of

Oncology doi:10.1093/annonc/mdp492

K McPherson, C M Steel, J M Dixon 2000. ABC of Breast Diseases – Breast

cancer – epidermiology,risk factors and genetics. British Medical

Journal2000;321:6248

KEMENTERIAN KESEHATAN REPUBLIK INDONESIA (2014) – Hilangkan

mitos tentang kanker. Available online at

http://www.depkes.go.id/article/print/201407070001/hilangkan-mitos-tentang-kanker.html (Diakses 29 April 2015)

Manuaba T.W. (2010) Panduan Pentalaksanaan Kanker Payudara.Panduan

Pentalaksanaan Kanker Payudara in Panduan Penatalaksanaan Kanker

Solid Peraboi 2010 Published by Sagung Seto, 17

(3)

31

Nadine M. Tung, Beth Israel, Eric P. Winer, Dana-Farber 2015.Tumor-Infiltrating

Lymphocytes and Response to Platinum in Triple-Negative Breast

Cancer.Journal of Clinical Oncology Vol 33, No 9 : pp969-971

R. Salgado, et. al. 2014. The evaluation of tumor-infiltrating lymphocytes (TILs)

in breast cancer: recommendation by an International TILs Working

Group 2014. Annals of Oncology 26: 259–271, 2015

Rathore A., Goel M., Makker A., Kumar S., Srivastava AN. 2013.Prognostic

Impact of CD3 Tumor Infiltrating Lymphocytes in Triple-negative Breast

Cancer. Indian Journal of Clinical Practice, Vol. 24, No. 4

William D. Foulkes, M.B., B.S., Ph.D., Ian E. Smith, M.D.,and Jorge S.

Reis-Filho, M.D., Ph.D. 2010 Triple-Negative Breast Cancer. The New

England Journal of Medicine 2010;363:1938-48.

World Health Organisation (WHO), Breast Cancer : prevention and control –

breast cancer burden. (2013). Available online at

http://www.who.int/cancer/detection/breastcancer/en/index1.html

(Diakses 14 Mei 2015)

World health Organization (WHO), Guidelines for management of breast cancer

(2006) Available online at

http://applications.emro.who.int/dsaf/dsa697.pdf (Diakses 10 Mei 2015)

Zun-Jiang Xie, Li-Min Jia, Ye-Chun He, Jiang-Tao Gao 2006. Morphological

observation of tumor infiltrating immunocytes in human rectal

cancer.World Journal of Gastroenterology 12(11): 1757-1760

Referensi

Dokumen terkait

bertentangan dengan asas-asas hukum, maka ketentuan itu pasti tidka adil. bertolak dari asas hukum di atas, maka sekalipun dalam Undang-Undang Nomor 22 Tahun 2009

[r]

Pada tanggal 30 September 2010 dan 30 September 2009, aktiva tetap berupa bangunan serta kendaraan perusahaan dan anak perusahaan, telah diasuransikan kepada PT Asuransi Wahana Tata

Tujuan penulis melakukan penelitian terhadap kebijakan moneter bank mandiri terhadap menentukan tingkat suku bunga deposito berjangka dengan jumlah deposito berjangka, selama 24

[r]

Kegagalan dan keberhasilan suatu perusahaan sangat tergantung dari kemampuan manajemen dalam mengambil keputusan yang menyangkut masalah yang dihadapi dengan berbagai macam

Untuk pengujian Ho1 menggunakan uji t-test dengan hasil Ho1 diterima yang berarti bahwa harga saham sebelum dan sesudah publikasi tidak berbeda atau berarti informasi publikasi

Paket pengadaan ini terbuka untuk penyedia barang/jasa yang memenuhi persyaratan, dengan terlebih dahulu melakukan registrasi pada Layanan Pengadaan Secara Elektronik